Author

Yoko K. Takada

University of California Davis Medical CenterPrimary ORCID profile (0000-0002-2381-124X · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Yoko K. TakadaiD1 paper · Immunology Frontier Research Center, The University of Osaka

Biology Disciplines

Click to filter author papers

Biochemistry· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2

Frequent Co-Authors

David Wei· 2 shared Samuel T. HwangiD· 2 shared Xueson Wu· 2 shared Yoshikazu TakadaiD· 2 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

David Wei

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

FGF2 binds to the allosteric site (site 2) and activates integrin αIIbβ3 and FGF1 binds to site 2 but suppresses integrin activation by FGF2: A potential mechanism of anti-thrombotic action of FGF1.

Yoko K. Takada, Xueson Wu, David Wei, Samuel T. Hwang, Yoshikazu Takada

This study shows FGF2 activates integrin αIIbβ3 via site 2, while FGF1 binds site 2 but inhibits FGF2-induced activation, suggesting FGF1's anti-thrombotic mechanism.

bioRxiv · Apr 17, 2024 · PreprintBiochemistry

FGF2 binds to the allosteric site (site 2) and activates αvβ3 integrin and FGF1 binds to site 2 but suppresses integrin activation by FGF2: a potential mechanism of anti-inflammatory action of FGF1

Yoko K. Takada, Xueson Wu, David Wei, Samuel T. Hwang, Yoshikazu Takada

This study shows FGF2 activates αvβ3 integrin via site 2, while FGF1 binds site 2 but suppresses integrin activation, suggesting FGF1's anti-inflammatory action is through blocking site 2.

bioRxiv · Apr 17, 2024 · PreprintBiochemistry